Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03397654
Title Study of Pembrolizumab Following TACE in Primary Liver Carcinoma (PETAL)
Acronym PETAL
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Imperial College London
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Imperial College Healthcare NHS Trust London United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field